DSM AND EVONIK ESTABLISH


VERAMARIS JOINT VENTURE DSM and Evonik have established a new company, Veramaris V.O.F., for the production of omega-3 fatty acids EPA and DHA from natural marine algae for animal nutrition. The 50:50 joint venture is headquartered at the DSM Biotech Campus in Delft (Netherlands). Veramaris’s breakthrough innovation –


an algal oil – will, for the first time, enable the production of the omega-3 fatty acids EPA and DHA for animal nutrition without using fish oil from wild-caught fish, a finite resource. DSM and Evonik announced their intention to start this joint venture in March 2017. Since then, all necessary approvals have been received. Construction of the US$200 million


production facility at the Evonik site in Blair, Nebraska, has commenced and is proceeding according to plan. Commercial quantities of the algal oil rich in the essential omega-3 fatty acids EPA and DHA will be ready for sale in 2019. Pilot quantities for market development purposes are already available. The initial annual production capacity will meet roughly 15% of the total current annual demand for EPA and DHA by the salmon aquaculture industry. Veramaris will be headed by CEO Karim


Kurmaly and CFO Frank Beissmann. Marine biologist Kurmaly has been with DSM for more than 16 years, most recently as Vice President Animal Nutrition & Health in Asia Pacific. Beissmann, an engineer, has been with Evonik for more than 20 years and has held various positions in production, supply chain, marketing and controlling. “Our algal oil, rich in both EPA and


DHA, is our response to the industry’s call for a sustainable and traceable source of the


omega-3 fatty acids EPA and DHA. Veramaris will now enable our partners along the value chain to grow in a responsible way and meet the demand for healthy animal protein rich in both EPA and DHA for consumer health,” says Kurmaly. Veramaris engages in dialogue with


all stakeholders across the value chain, including NGOs. Pioneering collaborations have allowed leading players in aquaculture to develop salmon diets free from marine ingredients, using the Veramaris algal oil as a complete replacement for fish oil. Until recently, the omega-3 fatty acids


EPA and DHA added to animal feed have been almost exclusively from marine sources such as fish oil and fishmeal, which are finite resources. Currently, a total of 16 million metric tons of wild fish are caught for the production of fish oil and fishmeal. By using natural marine algae, Veramaris contributes to closing the omega-3 EPA and DHA supply- demand gap, while helping to conserve marine life and biodiversity in the oceans.


EVONIK AND FUFENG GROUP ENTER STRATEGIC PARTNERSHIP FOR THE PRODUCTION OF


THREAMINO® Evonik and the Fufeng Group have entered into a cooperation agreement for the production of ThreAMINO®


The Chinese specialist in bio-fermentation will toll manufacture ThreAMINO®


(L-threonine). using


Evonik’s technology. This strategic partnership supports Evonik’s positioning and efficiency in the animal nutrition segment. For the first time, Evonik is now able to offer ThreAMINO® worldwide with a lean asset footprint.


BLUESTAR ADISSEO ANNOUNCES C LOS ING OF NUT R I AD


ACQUISITION Bluestar Adisseo announced that it has completed the acquisition of global feed additives producer Nutriad. This transaction is part of Adisseo’s strategy to become one of the worldwide leaders of specialty additives in animal nutrition. “We are pleased to have quickly


brought the Nutriad acquisition to completion and excited to welcome Nutriad talents in the Adisseo team. This complementary combinat ion suppor ts our st rategy for accelerating growth of our Specialty products business. Together, we will set up an efficient organization which should allow us to strengthen our global product portfolio’s competitiveness and its overall efficiency” said Adisseo CEO Jean-Marc Dublanc. Nutriad CEO Erik Visser added: “The


announcement of the acquisition of Nutriad by Adisseo has been met with overwhelming enthusiasm by our customers, suppliers, distribution partners and employees across the world.” Nutriad’s product range, the species


addressed and its customers are highly complementary to Adisseo’s and will allow the combined business to implement integrated solutions and offer even more value to customers. A joint Adisseo/Nutriad project group


has been set up and is already working on identifying and implementing the synergies.


For over 40 years, TIMAB has been supplying high quality inorganic minerals. Its technical innovation and business model have seen the group emerge as a key supplier in the animal feed industry. Now, as producers of calcined magnesium oxide (CCM) this innovation can be passed on to our customers.


No catalogues, just solutions.


Here at TIMAB Magnesium, we leave nothing to chance. Each customer is unique to us, therefore, so is each response. TIMABMagnesium doesn’t compromise – we follow just one guideline: the excellence of our products, judged by the satisfaction of our customers. In addition to our own magnesium mines, we have an expansive network of partners. Thanks to this dual approach, we have access to a vast range of the most bioavailable and digestible magnesium oxide sources on themarket.


So, whatever your need, you can always rely on the knowledge and expertise of TIMABMagnesium.


You can contact Jonathon Roscoe (above) for the UK and Ireland: By phone: +44 (0)7496 042 980 By email: jonathon.roscoe@roullier.com Website: timabmagnesium.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68